Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDD.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HW.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GE.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.5.1.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCHEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JF.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDSEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LY.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDQ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GW.5.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.23.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JE.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.83EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.24.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1.8.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MD.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.64.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDP.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KR.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KZ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KS.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
JN.1.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used